Story thread · 2 reports / 2 sources
STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
statnews.com · 2h · first report
German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.
The coverage
- Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharmadive.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.